Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Archives of Orthopaedic and Trauma Surgery|January 11, 2025
Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic reviewMaria Anna Smolle, Markus G Seidel, Karl Kashofer, et al.
The American Journal of Pathology|January 1, 2016
Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR PathwayStephan W Jahn, Karl Kashofer, Andrea Thüringer, et al.
Clinical Science (London, England : 1979)|November 4, 2018
Gestational diabetes alters microRNA signatures in human feto-placental endothelial cells depending on fetal sexJasmin Strutz, Silvija Cvitic, Hubert Hackl, et al.
Wiener Klinische Wochenschrift|September 15, 2020
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver diseaseStefan Traussnigg, Emina Halilbasic, Harald Hofer, et al.
Transfusion|July 28, 2007
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cellsKatharina Schallmoser, Christina Bartmann, Eva Rohde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 14, 2015
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysisStephan W Jahn, Karl Kashofer, Iris Halbwedl, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2025
EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinomaSonia Gatius, Marta Vaquero, Oliver Scheiber, et al.
Translational Lung Cancer Research|December 13, 2024
Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutationGerhard Hamilton, Sandra Stickler, Mikhail Ermakov, et al.
Pageof 12